Andrew Arno - 17 Aug 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Issuer symbol
OCX
Transactions as of
17 Aug 2022
Net transactions value
+$13,500
Form type
4
Filing time
19 Aug 2022, 08:00:26 UTC
Previous filing
17 Aug 2022
Next filing
28 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $6,750 +7,500 +100% $0.9000 15,000 17 Aug 2022 See footnote F1, F2
transaction OCX Common Stock, no par value Purchase $6,750 +7,500 +100% $0.9000 15,000 17 Aug 2022 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $0.90 per share represents a weighted average of prices ranging from $0.88 to $0.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The shares of common stock are held by JBA Investments LLC. The Reporting Person is the Manager of JBA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
F3 The shares of common stock are held by MJA Investments LLC. The Reporting Person is the Manager of MJA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.